Avalo insider plans sale after option exercise
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Avalo Therapeutics, Inc. (AVTX) reports that an affiliate, Morgan Stanley Smith Barney LLC Executive Financial Services, intends to sell common stock on behalf of a party identified in the notice. The planned transaction covers 679 shares of common stock in connection with an exercise of stock options for cash on 08/10/2026.
The notice also lists prior common stock sales for Mittie Doyle under a Rule 10b5-1 trading plan over the past three months, including transactions on 05/15/2026, 05/28/2026, 06/23/2026, 06/30/2026, and 07/27/2026 with share counts ranging from 679 to 4,654 shares.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Exercise of Stock Options financial
Form 144 regulatory
Executive Financial Services financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is being reported for AVTX in this Form 144 notice?
How is the AVTX stock being acquired before the planned sale on 08/10/2026?
What past Rule 10b5-1 sales for AVTX stock by Mittie Doyle are disclosed?
What were the largest recent AVTX stock sales under the 10b5-1 plan?
Who is identified in connection with the recent AVTX 10b5-1 stock sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.